The Orca Dental AI CephX platform has received U.S. Food and Drug Administration (FDA) clearance for 3D imaging.
The new CephX3D tool is designed to analyze cone-beam computed tomography scans, segment key anatomical structures, and include a web-based 3D viewer for treatment planning support.
Additionally, the company announced new integrations with imaging platform DEXIS and practice management software Greyfinch, allowing clinicians to access AI-powered cephalometric analysis directly in their existing workflows.
